Literature DB >> 10970248

Novel Fosfomycin resistance of Pseudomonas aeruginosa clinical isolates recovered in Japan in 1996.

M Shimizu, F Shigeobu, I Miyakozawa, A Nakamura, M Suzuki, S Mizukoshi, K O'Hara, T Sawai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10970248      PMCID： PMC90005          DOI： 10.1128/AAC.44.7.2007-2008.2000

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  8 in total

Review 1.  Plasmid-encoded fosfomycin resistance.

Authors:  J E Suárez; M C Mendoza
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

2.  Fosfomycin resistance in Escherichia coli in Japan.

Authors:  M Shimizu; T Nonomiya; F Shigenobu; K O'Hara; T Sawai
Journal:  J Antibiot (Tokyo)       Date:  1998-09       Impact factor: 2.649

3.  Characterization of the fomA and fomB gene products from Streptomyces wedmorensis, which confer fosfomycin resistance on Escherichia coli.

Authors:  S Kobayashi; T Kuzuyama; H Seto
Journal:  Antimicrob Agents Chemother       Date:  2000-03       Impact factor: 5.191

4.  Two different types of fosfomycin resistance in clinical isolates of Klebsiella pneumoniae.

Authors:  K O'Hara
Journal:  FEMS Microbiol Lett       Date:  1993-11-15       Impact factor: 2.742

5.  A new simple assay for determining aminoglycoside inactivation in intact cells of Pseudomonas aeruginosa.

Authors:  K O'Hara; T Kawabe; K Taniguchi; M Ohnuma; M Nakagawa; Y Naitou; T Sawai
Journal:  Microbios       Date:  1997

6.  Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey.

Authors:  P Arca; G Reguera; C Hardisson
Journal:  J Antimicrob Chemother       Date:  1997-09       Impact factor: 5.790

7.  Fosfomycin and plasmidic resistance.

Authors:  F Baquero; M López-Brea; A Valls; T Cañedo
Journal:  Chemotherapy       Date:  1977       Impact factor: 2.544

8.  The microbiological efficacy of the combination of fosfomycin and vancomycin against clinically relevant staphylococci.

Authors:  S Gatermann; E Schulz; R Marre
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553
  8 in total
  10 in total

1.  Role of the CpxAR two-component signal transduction system in control of fosfomycin resistance and carbon substrate uptake.

Authors:  Kumiko Kurabayashi; Yuko Hirakawa; Koichi Tanimoto; Haruyoshi Tomita; Hidetada Hirakawa
Journal:  J Bacteriol       Date:  2013-10-25       Impact factor: 3.490

Review 2.  Fosfomycin: an old, new friend?

Authors:  M Popovic; D Steinort; S Pillai; C Joukhadar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-11-14       Impact factor: 3.267

3.  Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods.

Authors:  Ching-Lan Lu; Chia-Ying Liu; Yu-Tsung Huang; Chun-Hsing Liao; Lee-Jene Teng; John D Turnidge; Po-Ren Hsueh
Journal:  Antimicrob Agents Chemother       Date:  2011-06-13       Impact factor: 5.191

4.  Identification of a second two-component signal transduction system that controls fosfomycin tolerance and glycerol-3-phosphate uptake.

Authors:  Kumiko Kurabayashi; Yuko Hirakawa; Koichi Tanimoto; Haruyoshi Tomita; Hidetada Hirakawa
Journal:  J Bacteriol       Date:  2014-12-15       Impact factor: 3.490

Review 5.  Differences in Fosfomycin Resistance Mechanisms between Pseudomonas aeruginosa and Enterobacterales.

Authors:  Dina Zheng; Phillip J Bergen; Cornelia B Landersdorfer; Elizabeth B Hirsch
Journal:  Antimicrob Agents Chemother       Date:  2021-11-22       Impact factor: 5.938

6.  Crystal structure of fosfomycin resistance kinase FomA from Streptomyces wedmorensis.

Authors:  Svetlana Pakhomova; Sue G Bartlett; Alexandria Augustus; Tomohisa Kuzuyama; Marcia E Newcomer
Journal:  J Biol Chem       Date:  2008-08-12       Impact factor: 5.157

7.  Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin.

Authors:  M E Falagas; M D Kanellopoulou; D E Karageorgopoulos; G Dimopoulos; P I Rafailidis; N D Skarmoutsou; E A Papafrangas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-23       Impact factor: 3.267

8.  Elevated Expression of GlpT and UhpT via FNR Activation Contributes to Increased Fosfomycin Susceptibility in Escherichia coli under Anaerobic Conditions.

Authors:  Kumiko Kurabayashi; Koichi Tanimoto; Shinobu Fueki; Haruyoshi Tomita; Hidetada Hirakawa
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

9.  Antibacterial activities of a fosfomycin/tobramycin combination: a novel inhaled antibiotic for bronchiectasis.

Authors:  David L MacLeod; Lynn M Barker; Jennifer L Sutherland; Suzanne C Moss; Jesse L Gurgel; Thomas F Kenney; Jane L Burns; William R Baker
Journal:  J Antimicrob Chemother       Date:  2009-08-13       Impact factor: 5.790

Review 10.  Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance.

Authors:  Alfredo Castañeda-García; Jesús Blázquez; Alexandro Rodríguez-Rojas
Journal:  Antibiotics (Basel)       Date:  2013-04-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.